Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24
CNBC's "Fast Money"
00:00
Stock Performance, Biotech Trial Results, and Market Update
Exploring the past challenges and future outlook of a particular stock, along with analyzing the influence of a biotech company's drug trial results on heart disease-related stocks. Additionally, providing insights on market movements including the Dow, S&P, and NASDAQ, discussing the impact of recent events on cryptocurrency and CPAP makers' stocks.
Play episode from 25:36
Transcript
